These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3615574)

  • 1. Neuroleptic malignant syndrome: observations on altered consciousness.
    Deuschl G; Oepen G; Hermle L; Kindt H
    Pharmacopsychiatry; 1987 Jul; 20(4):168-70. PubMed ID: 3615574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fever and altered consciousness are not always equal to central nervous system infection: neuroleptic malignant syndrome in a 15-year-old girl.
    Unal F; Hizli S; Ozyürek H; Sonuvar B
    Turk J Pediatr; 1996; 38(4):505-10. PubMed ID: 8993181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM; Shifrar KA
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comatose patient with neuroleptic malignant syndrome brought by ambulance].
    Takinami Y; Kuroda Y
    Masui; 2012 Jan; 61(1):79-81. PubMed ID: 22338865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The malignant neuroleptic syndrome and malignant hyperthermia].
    Mitterschiffthaler G; Hackl JM; Neumann R
    Anaesthesist; 1989 Apr; 38(4):210-3. PubMed ID: 2729540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.
    Harsch HH
    J Clin Psychiatry; 1987 Aug; 48(8):328-33. PubMed ID: 2886491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome.
    Paul GE; Landers DF; Newman T
    Nebr Med J; 1990 Mar; 75(3):46-9; discussion 49-50. PubMed ID: 2179748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuroleptic malignant syndrome--a review.
    Gibb WR; Lees AJ
    Q J Med; 1985 Aug; 56(220):421-9. PubMed ID: 2864716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Torecan-induced neuroleptic malignant syndrome].
    Bulvik S; Shimoni Z; Kaplan CL
    Harefuah; 1990 May; 118(10):576-8. PubMed ID: 2358219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome: a review of literature].
    Crespo Facorro B; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(5):273-8. PubMed ID: 8553925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroleptic malignant syndrome, multiorgan failure and peripheral polyneuropathy].
    Mesejo A; Núñez C; Simó M; Blanquer J; Pérez PL; Ruiz F; Cuñat J
    Rev Neurol; 1995; 23(119):136-8. PubMed ID: 8548608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
    Lee JW
    J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of malignant neuroleptic syndrome with rhabdomyolysis and a therapeutic trial using physostigmine].
    Krull F; Risse A
    Fortschr Neurol Psychiatr; 1986 Dec; 54(12):398-401. PubMed ID: 2880787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of neuroleptic malignant syndrome with anticholinergic medication.
    Hasan MY; Schauben JL; Holmes CH
    Vet Hum Toxicol; 1999 Apr; 41(2):79-81. PubMed ID: 10192135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.